SOD2 deficient erythroid cells up-regulate transferrin receptor and down-regulate mitochondrial biogenesis and metabolism

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Martin, Florent M ^a   Xu, Xiuling ^a   von Löhneysen, Katharina ^a   Gilmartin, Timothy J ^a   Friedman, Jeffrey S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRANSFERRIN RECEPTOR; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BIOGENESIS; CONTROLLED STUDY; DOWN REGULATION; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; SIDEROBLASTIC ANEMIA; UNINDEXED SEQUENCE; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

MURINAE; MUS;

ANEMIA, SIDEROBLASTIC; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ERYTHROBLASTS; ERYTHROID CELLS; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; RECEPTORS, TRANSFERRIN; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 79951520304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016894     Document Type: Article

References (51)

1. Friedman JS, Rebel VI, Derby R, Bell K, Huang TT, et al. (2001) Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med 193: 925-934.
2. Bottomley SS, (2006) Congenital sideroblastic anemias. Curr Hematol Rep 5: 41-49.
3. Alcindor T, Bridges KR, (2002) Sideroblastic anaemias. Br J Haematol 116: 733-743.
4. Fleming MD, (2002) The genetics of inherited sideroblastic anemias. Semin Hematol 39: 270-281.
5. May A, Fitzsimons E, (1994) Sideroblastic anaemia. Baillieres Clin Haematol 7: 851-879.
6. Cotter PD, Rucknagel DL, Bishop DF, (1994) X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood 84: 3915-3924.
7. Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, et al. (1999) Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 8: 743-749.
8. Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N, (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74: 1303-1308.
9. Patton JR, Bykhovskaya Y, Mengesha E, Bertolotto C, Fischel-Ghodsian N, (2005) Mitochondrial myopathy and sideroblastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation. J Biol Chem 280: 19823-19828.
10. Bykhovskaya Y, Mengesha E, Fischel-Ghodsian N, (2007) Pleiotropic effects and compensation mechanisms determine tissue specificity in mitochondrial myopathy and sideroblastic anemia (MLASA). Mol Genet Metab 91: 148-156.
11. Pearson HA, Lobel JS, Kocoshis SA, Naiman JL, Windmiller J, et al. (1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 95: 976-984.
12. Camaschella C, Campanella A, De Falco L, Boschetto L, Merlini R, et al. (2007) The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 110: 1353-1358.
13. Guernsey DL, Jiang H, Campagna DR, Evans SC, Ferguson M, et al. (2009) Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 41: 651-653.
14. Bergmann AK, Campagna DR, McLoughlin EM, Agarwal S, Fleming MD, et al. (2009) Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations. Pediatr Blood Cancer.
15. Gattermann N, Retzlaff S, Wang YL, Hofhaus G, Heinisch J, et al. (1997) Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood 90: 4961-4972.
16. Gattermann N, Wulfert M, Junge B, Germing U, Haas R, et al. (2004) Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome. Blood 103: 1499-1502.
17. Gattermann N, (2000) From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leuk Res 24: 141-151.
18. Gattermann N, Retzlaff S, Wang YL, Berneburg M, Heinisch J, et al. (1996) A heteroplasmic point mutation of mitochondrial tRNALeu(CUN) in non- lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroblastic anaemia. Br J Haematol 93: 845-855.
19. Wang YL, Choi HK, Aul C, Gattermann N, Heinisch J, (1999) The MERRF mutation of mitochondrial DNA in the bone marrow of a patient with acquired idiopathic sideroblastic anemia. Am J Hematol 60: 83-84.
20. Shin MG, Kajigaya S, Levin BC, Young NS, (2003) Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood 101: 3118-3125.
21. Beck EA, Ziegler G, Schmid R, Ludin H, (1967) Reversible sideroblastic anemia caused by chloramphenicol. Acta Haematol 38: 1-10.
22. Sharp RA, Lowe JG, Johnston RN, (1990) Anti-tuberculous drugs and sideroblastic anaemia. Br J Clin Pract 44: 706-707.
23. Yunis AA, Salem Z, (1980) Drug-induced mitochondrial damage and sideroblastic change. Clin Haematol 9: 607-619.
24. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, et al. (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381.
25. Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, et al. (2004) SOD2 Deficiency Anemia: Protein Oxidation and Altered Protein Expression Reveal Targets of Damage, Stress Response and Anti-oxidant Responsiveness. Blood 104: 2565-2573.
26. Martin FM, Bydlon G, Welsh ML, Friedman JS, (2005) A method for rapid mouse siderocyte enrichment. Exp Hematol 33: 1493-1499.
27. Martin FM, Bydlon G, Friedman JS, (2006) SOD2-deficiency sideroblastic anemia and red blood cell oxidative stress. Antioxid Redox Signal 8: 1217-1225.
28. Martin FM, Prchal J, Nieva J, Saven A, Andrey J, et al. (2008) Purification and Characterization of Sideroblasts from Patients with Acquired and Hereditary Sideroblastic Anemia. British Journal of Haematology in press.
29. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, et al. (2001) Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98: 3261-3273.
30. Zhang J, Socolovsky M, Gross AW, Lodish HF, (2003) Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 102: 3938-3946.
31. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
32. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, et al. (2003) MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4: R7.
33. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, et al. (1999) Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A 96: 846-851.
34. Burgess SC, He T, Yan Z, Lindner J, Sherry AD, et al. (2007) Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab 5: 313-320.
35. Wallace DC, (1999) Mitochondrial diseases in man and mouse. Science 283: 1482-1488.
36. Wallace DC, (2001) A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp 235: 247-263; discussion 263-246.
37. Andersson U, Scarpulla RC, (2001) Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol 21: 3738-3749.
38. Scarpulla RC, (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88: 611-638.
39. Spiegelman BM, (2007) Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp 287: 60-63; discussion 63-69.
40. Sankaran VG, Orkin SH, Walkley CR, (2008) Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev 22: 463-475.
41. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, et al. (1998) Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18: 231-236.
42. Klausner RD, Rouault TA, Harford JB, (1993) Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72: 19-28.
43. Rouault TA, (2006) The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2: 406-414.
44. Hentze MW, Rouault TA, Caughman SW, Dancis A, Harford JB, et al. (1987) A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. Proc Natl Acad Sci U S A 84: 6730-6734.
45. Boultwood J, Pellagatti A, Nikpour M, Pushkaran B, Fidler C, et al. (2008) The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS ONE 3: e1970.
46. Srinivasan V, Netz DJ, Webert H, Mascarenhas J, Pierik AJ, et al. (2007) Structure of the yeast WD40 domain protein Cia1, a component acting late in iron-sulfur protein biogenesis. Structure 15: 1246-1257.
47. Balk J, Aguilar Netz DJ, Tepper K, Pierik AJ, Lill R, (2005) The essential WD40 protein Cia1 is involved in a late step of cytosolic and nuclear iron-sulfur protein assembly. Mol Cell Biol 25: 10833-10841.
48. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675-1680.
49. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300.
50. Hochberg Y, Benjamini Y, (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818.
51. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.